Published trade mark details for 2298981
This information was published on 2022-09-19T16:25:22 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2298981 (IR 1682035) |
| (220) |
28 Dec 2021
|
| (300) |
DE, 16 Dec 2021, 30 2021 120 510
DE, 25 Aug 2021, 30 2021 114 486 |
| (500) |
The applicant has advised that the words in the Mark have no meaning in English
|
| (511) (510) |
Class 1
Chemicals for use in pharmaceutical industry; active chemical ingredients for use in manufacture of anti-cancer drugs and vaccines; adjuvants for use in manufacture of vaccines; nucleic acids, proteins and peptides for laboratory use; diagnostic preparations for scientific or research use. Class 5 Pharmaceutical and medicinal preparations and substances except vitamin preparations, mineral food supplements, probiotics, omega 3 preparations, dietetic substances and food supplements for medical and non-medical purposes; pharmaceutical products for the prevention and treatment of cancer, infectious diseases, and immunological diseases, except vitamin preparations, mineral food supplements, probiotics, omega 3 preparations, dietetic substances and food supplements for medical and non-medical purposes; vaccines; chemical reagents used for medical purposes; biochemical reagents used for purposes for the treatment of cancer, treatment of immunological diseases, and treatment of infectious diseases; macromolecules, namely, nucleic acid sequences and proteins, used for medical and veterinary purposes; cell based immune therapeutics for treatment of cancer, treatment of immunological diseases, and treatment of infectious diseases; diagnostic preparations for clinical or medical laboratory use. Class 9 Mobile apps and computer software to enable healthcare professionals and patients to access information on pharmaceutical, medical and vaccine products and services; e-commerce software to enable users to perform electronic business transactions via a global computer network. Class 10 Surgical and medical apparatus and instruments; medical diagnostic devices; medical diagnostic devices for analysis of body fluids and biopsies for diagnosis and monitoring of cancer, infectious diseases, and immunological diseases; medical diagnostic devices for analysis of body fluids and biopsies for patient stratification. Class 35 Provision of information and advisory services relating to electronic commerce; retail or wholesale services of pharmaceutical products; retail or wholesale services of medicinal preparations; retail or wholesale services of medical supplies. Class 42 Scientific research for medical purposes; medical and scientific research in the field of treatment of immunological diseases, cancer treatment, and treatment of infectious diseases; providing medical and scientific research information, consultancy, and advisory services, all in the fields of treatment of immunological diseases, cancer treatment, and treatment of infectious diseases; medical and scientific research services by compiling data for clinical trials and drug admission. Class 44 Medical, hygienic and beauty care; healthcare services; provision of medical information and services; provision of information to patients and healthcare professionals concerning pharmaceutical products, vaccines, medical products, medical diseases and disorders and related treatments via the internet; medical services in the field of gene therapy; medical services in the field of cell therapy; medical and psychological counselling services; health counseling and medical services; medical services, namely, providing therapies for treating cancer, infectious diseases and immunological diseases; veterinary services, namely, providing therapies for treating cancer, infectious diseases, and immunological diseases; medical and pharmaceutical consultation; medical diagnostic testing, monitoring and reporting services; genetic testing for medical purposes; provision of customer information on pharmaceutical and medical products through an on-line computer network. |
| (540) |
|
| (550) | Figurative |
| (730) |
BioNTech SE
|
Find out more about publications on the About page.